Peak6 »

Intellia Therapeutics shares owned by Peak6

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Peak6 from 13F filings

Historical chart of Peak6 investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Peak6 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Peak6

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.9M 344k 17.27
2025-06-30 $1.5M 162k 9.38
2025-03-31 $796k 112k 7.11
2024-12-31 $1.6M 136k 11.66

More positions owned by Peak6

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Coreweave Com Cl A Call Option (CRWV)
Apple Call Option (AAPL)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New Call Option (MSTR)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Broadcom Call Option (AVGO)

View all positions for Peak6

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
Contrarius Group Holdings
State Street Corporation
Goldman Sachs Group
Morgan Stanley
Regeneron Pharmaceuticals
Baker Bros. Advisors
Geode Capital Management
Two Sigma Investments
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
D. E. Shaw & Co
Two Sigma Advisers

View all funds holding Intellia Therapeutics